Supernus to Host First Quarter 2015 Earnings Conference Call

ROCKVILLE, Md., April 21, 2015 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report the financial results for the first quarter of 2015 after 5:00 PM ET on Tuesday, May 5, 2015.

Jack Khattar, President and Chief Executive Officer and Greg Patrick, Chief Financial Officer, will host a conference call to present the first quarter 2015 results on Wednesday, May 6, 2015 at 9:00 AM ET. Following the presentation, the call will be open for questions.

A live webcast will be available at www.supernus.com. Following the live call, a replay will be available on the Company's website under the 'Investors' section. The webcast will be available on the Company's website for 60 days following the live call.

Please refer to the information below for conference call dial-in information. Callers should dial in approximately 10 minutes prior to the start of the call.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The Company has two marketed products for epilepsy, Oxtellar XR® (extended-release oxcarbazepine) and Trokendi XR® (extended-release topiramate). The Company is also developing several product candidates to address large market opportunities in psychiatry. These product candidates include SPN-810 for the treatment of impulsive aggression in patients with ADHD in conjunction with standard ADHD treatment and SPN-812 for ADHD.

CONTACT: Jack A. Khattar, President and CEO
         Gregory S. Patrick, Vice President and CFO
         Supernus Pharmaceuticals, Inc.
         301-838-2591

         or

         INVESTOR CONTACT:
         Peter Vozzo
         Westwicke Partners
         Office: (443) 213-0505
         Mobile: (443) 377-4767
         Email: [email protected]

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Top software application stocks to watch, according to Oppenheimer
• BRC Group Holdings to acquire Sangoma Technologies for ~$204M